WizCommerce | $8,000,000 | (Aug 27, 2025)
Nugen | Undisclosed Amount | (Aug 27, 2025)
AiGent | $6,000,000 | (Aug 27, 2025)
Predicta Biosciences
United States
- Cambridge, Massachusetts
- 17/07/2024
- Seed
- $5,200,000
Predicta Biosciences is a precision oncology company integrating cutting edge multiomics and liquid biopsies to develop innovative diagnostic and therapeutic products. Predicta's diagnostic product portfolio removes the burden of bone-marrow biopsies, through small blood-based samples, and enables best-in-class treatment decision-making for immunotherapies. Utilizing the data from the diagnostic platform, Predicta has an in-house therapeutic pipeline of novel immunotherapy targets in pre-clinical discovery and development.
- Industry Biotechnology Research
- Website https://www.predictabiosciences.com/
- LinkedIn https://www.linkedin.com/company/predicta-biosciences/
Related People
Kate (Gallagher) CavesFounder
United States -
Greater Boston
Executive Leader with Business Development, Corporate Development, Marketing and deep technical background in Therapeutic Development and Diagnostic tools. Passionate about the intersection of Biology, Healthcare, and AI.
Peeko | $3,200,000 | (Aug 27, 2025)
Reframe Systems | $20,000,000 | (Aug 27, 2025)
Palabra.ai | $8,400,000 | (Aug 27, 2025)
Lumaegis | $200,000,000 | (Aug 27, 2025)
Aurasell AI | $30,000,000 | (Aug 27, 2025)
Loman AI | $3,500,000 | (Aug 27, 2025)
LO:TECH | $5,000,000 | (Aug 27, 2025)
Therna Biosciences | $10,000,000 | (Aug 27, 2025)
Hades Mining | $6,398,622 | (Aug 27, 2025)
Pageport | $3,300,000 | (Aug 27, 2025)